v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05919472 |
Full text link
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
giulia.pironaci@hest.ethz.ch |
Registration date
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
2023-06-26 |
Recruitment status
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Not recruiting |
Study design
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Prevention |
Inclusion criteria
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
inclusion criteria: willing and able to give informed consent for participation in the trial female aged 18-49 years moderate anemia (hb <110 g/l, but not severely anemic with hb <80 g/l) • iron deficient (znpp >40 mmol/mol haem) anticipated residence in the study area for the study duration |
Exclusion criteria
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
major chronic infectious disease (e.g., hiv infection); major chronic non-infectious disease (e.g., type 2 diabetes, cancer); chronic medications; use of iron-containing mineral and vitamin supplementation 2 weeks prior to study start; covid-19 vaccine or confirmed covid-19 infection within the past 2 years menacwy vaccine in the past pregnant (confirmed by rapid test during screening) or lactating. malaria (confirmed by rapid test) à study start will be postponed |
Number of arms
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
3 |
Funding
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Prof Simon Karanja |
Inclusion age min
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
49 |
Countries
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Kenya |
Type of patients
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
High risk patients |
Severity scale
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
180 |
primary outcome
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Anti-MenACWY IgG concentrations at study end;Anti-S1 and anti-RBD IgG concentrations against SARS-COV-2 at study end;Baseline anti-strike (S1) immunoglobulin (IgG) and anti-receptor-binding domain (RBD) IgG concentrations against severe acute respiratory syndrome (SARS)-Coronavirus (COV)-2;Baseline IgG concentration against meningococcal serogroups A, C, W, and Y (anti-MenACWY IgG) |
Notes
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : June 28, 2023, 4 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "nan", "treatment_id": 2753, "treatment_name": "Ad26.cov2.s+menacwy vaccine", "treatment_type": "Non replicating viral vector+non covid vaccine", "pharmacological_treatment": "Vaccine+non covid vaccine"}, {"arm_notes": "Oral iron supplementation (pre-treatment) ", "treatment_id": 2752, "treatment_name": "Ad26.cov2.s+iron+menacwy vaccine", "treatment_type": "Non replicating viral vector+vitamins and dietary supplements+non covid vaccine", "pharmacological_treatment": "Vaccine+pharmacological treatment+non covid vaccine"}, {"arm_notes": "Oral iron supplementation (simultaneous treatment) ", "treatment_id": 2752, "treatment_name": "Ad26.cov2.s+iron+menacwy vaccine", "treatment_type": "Non replicating viral vector+vitamins and dietary supplements+non covid vaccine", "pharmacological_treatment": "Vaccine+pharmacological treatment+non covid vaccine"}] |